Immunometabolism in rheumatoid arthritis: mechanisms, biomarkers, and the path to precision medicine.

Researchers have published a comprehensive review examining how immune cells change their energy metabolism in rheumatoid arthritis (RA), a chronic inflammatory condition causing joint pain and damage. The study analyzed how specific immune cells—including T cells, macrophages, B cells, and fibroblast-like synoviocytes—alter their energy production processes to fuel ongoing inflammation. These cells shift how they use sugar, fats, and oxygen to sustain the inflammatory response that damages joints. The review highlights emerging blood-based biomarkers that could help predict which patients will respond best to specific medications, moving toward more personalized treatment approaches. Importantly, the researchers explored how targeting these metabolic changes could offer new treatment options, including repurposing existing medications like metformin and developing new metabolic inhibitors. For patients with RA considering acupuncture, this research is relevant because acupuncture has been shown to modulate inflammation and immune function through different pathways. While this study doesn't directly investigate acupuncture, understanding that RA involves complex metabolic and immune dysregulation helps explain why integrative approaches addressing multiple biological systems may be beneficial. Acupuncture may complement conventional treatments by reducing inflammation, managing pain, and potentially influencing immune cell behavior. As precision medicine advances for RA, combining conventional targeted therapies with evidence-based complementary approaches like acupuncture could offer a more comprehensive treatment strategy tailored to individual patients' inflammatory profiles and treatment responses. To explore acupuncture as part of your RA management plan, seek a licensed acupuncturist with experience treating autoimmune and inflammatory conditions.

This comprehensive review examines immunometabolic dysregulation in rheumatoid arthritis, focusing on cell-type-specific metabolic reprogramming in T cells, macrophages, B cells, and fibroblast-like synoviocytes. The authors detail how pathogenic immune and stromal cells alter glycolysis, oxidative phosphorylation, and lipid metabolism to sustain chronic inflammation and joint destruction. The review assesses high-dimensional biomarkers including metabolomic, transcriptomic, and proteomic signatures for patient stratification and treatment response prediction. Novel therapeutic approaches targeting immunometabolic pathways are discussed, including metabolic inhibitors and drug repurposing strategies such as metformin. The authors propose integrating immunometabolic profiling into precision medicine frameworks for individualized RA management. Clinical relevance: Understanding these metabolic mechanisms may help practitioners contextualize how acupuncture's anti-inflammatory and immunomodulatory effects could complement targeted biologic therapies. This knowledge supports integrative treatment strategies addressing multiple pathophysiological pathways in RA management.